Copegus Approved In Japan As Combination Therapy With Pegasys For Patients With Chronic Hepatitis C

Mon, 29 Jan 2007 02:00 PM EST

... Roche and Chugai announced today that the combination of Copegus (ribavirin) plus Pegasys (peginterferon alfa-2a (40KD)) has been approved in Japan following fast track review by the Japanese regulatory agency (MHLW). This is good news for Japanese hepatitis C patients, who now have access to the world's gold standard treatment for the disease. [click link for full article] ...